"Heparin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts.
Concept/Terms
Heparin- Heparin
- Unfractionated Heparin
- Heparin, Unfractionated
- Heparinic Acid
Below are MeSH descriptors whose meaning is more general than "Heparin".
Below are MeSH descriptors whose meaning is more specific than "Heparin".
This graph shows the total number of publications written about "Heparin" by people in Harvard Catalyst Profiles by year, and whether "Heparin" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 11 | 13 | 24 |
| 1994 | 6 | 15 | 21 |
| 1995 | 11 | 12 | 23 |
| 1996 | 19 | 14 | 33 |
| 1997 | 14 | 14 | 28 |
| 1998 | 16 | 15 | 31 |
| 1999 | 20 | 11 | 31 |
| 2000 | 15 | 22 | 37 |
| 2001 | 18 | 24 | 42 |
| 2002 | 12 | 17 | 29 |
| 2003 | 16 | 15 | 31 |
| 2004 | 16 | 24 | 40 |
| 2005 | 10 | 15 | 25 |
| 2006 | 15 | 15 | 30 |
| 2007 | 20 | 19 | 39 |
| 2008 | 24 | 12 | 36 |
| 2009 | 7 | 9 | 16 |
| 2010 | 13 | 10 | 23 |
| 2011 | 10 | 6 | 16 |
| 2012 | 5 | 10 | 15 |
| 2013 | 10 | 4 | 14 |
| 2014 | 14 | 16 | 30 |
| 2015 | 13 | 10 | 23 |
| 2016 | 21 | 10 | 31 |
| 2017 | 21 | 5 | 26 |
| 2018 | 12 | 9 | 21 |
| 2019 | 19 | 7 | 26 |
| 2020 | 13 | 12 | 25 |
| 2021 | 17 | 16 | 33 |
| 2022 | 6 | 15 | 21 |
| 2023 | 1 | 2 | 3 |
Below are the most recent publications written about "Heparin" by people in Profiles.
-
Efficacy of Postpartum Pharmacologic Thromboprophylaxis: A Systematic Review and Meta-analysis. Obstet Gynecol. 2023 Apr 01; 141(4):697-710.
-
Design of an Ultralow Molecular Weight Heparin That Resists Heparanase Biodegradation. J Med Chem. 2023 02 09; 66(3):2194-2203.
-
Effective, safe and efficient porcine model of Forrest Ib bleeding gastric and colonic ulcers. Indian J Gastroenterol. 2023 Feb; 42(1):118-127.
-
Anticoagulation in adult patients supported with extracorporeal membrane oxygenation: guidance from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2023 02; 21(2):373-396.
-
Off-the-shelf cryopreserved platelets for the detection of HIT and VITT antibodies. Blood. 2022 12 22; 140(25):2722-2729.
-
Direct thrombin inhibitors as alternatives to heparin to preserve lung growth and function in a murine model of compensatory lung growth. Sci Rep. 2022 12 07; 12(1):21117.
-
Timing and choice of systemic anticoagulation in the setting of extremity arterial injury repair. Eur J Trauma Emerg Surg. 2023 Feb; 49(1):473-485.
-
Heparinized Gelatin-Based Hydrogels for Differentiation of Induced Pluripotent Stem Cells. Biomacromolecules. 2022 10 10; 23(10):4141-4152.
-
Improvement of Umbilical Cord Blood Gas Analysis with Implementation of Clot Catchers. J Appl Lab Med. 2022 09 01; 7(5):1158-1163.
-
Thromboprophylaxis with standard-dose vs. flexible-dose heparin for hospitalized COVID-19 patients: a target trial emulation. J Clin Epidemiol. 2022 11; 151:96-103.